Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Avalo Therapeutics Inc AVTX

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.


NDAQ:AVTX - Post by User

User Avatar Image
(1441)
•••
  • IseneschalX
Post by Iseneschalon Jan 29, 2024 1:36pm
67 Views
Post# 35850865

AVTX..Lol..looks like all the FOMO's are getting skittish

AVTX..Lol..looks like all the FOMO's are getting skittishI can see them placing little market oda's thus taking out the offer on this thinner.

Not me.....there is zero volume

All the Fomo's are seeing the Nano floaters share price increase dramatically


This could...but I'd wait for some volume
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities